Sciencebiotech
Manganese-doped carbon nanodots as next-gen MRI contrast agents
Researchers at CIC biomaGUNE have identified manganese-doped carbon nanodots as a promising alternative to traditional MRI contrast agents. These innovative compounds offer enhanced tissue differentiation and improved diagnostic visibility. The study, led by Lucia Cardo and Maurizio Prato, suggests that these nanodots could represent the next generation of medical imaging technology, potentially offering safer and more effective clinical analysis.